Hepatitis

The presence of _________ in a patient's serum is considered to represent recovery and immunologic protection from hepatitisB.

A.   
Anti-HBc

B.   
Anti-HBs

C.   
HBeAg

D.   
Anti-HAV

E.    
None of the above.

Persons with increased risk for infection with
Hepatitis A include ____________. 

A.   
persons who have clotting factor disorder

B.   
illicit drug users

C.   
travelers to intermediate and high HAV-endemic countries

D.   
persons with chronic liver disease

E.    
All of the above.

1.   
Germicides are tested for efficacy against
Hepatitis B virus using ____________.

A.   
purified human Hepatitis B virus

B.   
duck Hepatitis virus

C.   
bovine Hepatitis virus

D.   
None, germicides are not tested for efficacy against Hepatitis B virus.

1.   
________ of individuals infected with HBV
become chronic carriers.

A.   
1%-5%

B
5%-10%.   

C.   
10%-15%

D.   
15%-20%

1.   
____________ Immunity is conferred by the
administration of Hep B vaccine.

A.   
Artificial active

B.   
Artificial passive

C.   
Natural passive

D.   
Natural active

1.   
Hepatitis A can be characterized as
____________.

A.   
transmitted primarily via
the fecal-oral route

B.   
transmitted primarily through contaminated blood transfusions

C.   
transmitted primarily through unprotected sex

D.   
transmitted primarily through illicit injection drug use

1.   
____________ may be traced to contaminated
food or water, especially inadequately cooked shellfish.

A.   
Hepatitis A

B.   
Hepatitis B

C.   
PT-NANB

D.   
Both A and B.

E.    
All of the above.

1.   
____________ is least likely to include
jaundice as a clinical symptom.

A.   
Hepatitis A

B.   
Hepatitis B

C.   
Hepatitis C

D.   
Hepatitis D

1.   
The term "infectious" hepatitis is
no longer used, but was formerly considered a synonym for ____________.

A.   
hepatitis A

B.   
hepatitis B

C.   
hepatitis C

D.   
A, B and C

1.   
The outer protein coat of the virus, termed
hepatitis B surface antigen (HBsAg), is detectable in infected blood and saliva
as a surface component of the intact HBV. 

Disinfectants with the ability to destroy M. tuberculosis within a ten-minute exposure are NOT capable of inactivating HBV on surfaces.

A.   
Both statements are true.

B.   
First statement is true. 
Second statement is false.

C.   
First statement is false.  Second statement is true.

D.   
Both statements are false.

1.   
HBV can be transmitted through direct
contact.  HBV can be transmitted through indirect contact.

A.   
Both statements are true.

B.   
First statement is true. Second statement is false.

C.   
First statement is false. Second statement is true.

D.   
Both statements are false.

1.   
After receiving the Hepatitis _____
vaccination, healthcare professionals should receive a titer verify their
____________.

A.   
A / infectivity

B.   
C / immunity

C.   
B / infectivity

D.   
B / immunity

1.   
A symptom of jaundice in a patient may suggest
____________.

A.   
drug-induced hepatitis

B.   
type A hepatitis

C.   
type B hepatitis

D.   
ET-NANB hepatitis

E.    
Any of the above.

1.   
As patients recovered from hepatitis B,
antibodies to the antigen (anti-HBs) were found causing protection to future
attacks.  HBsAg forms are present in low concentration in carriers of
hepatitis B.

A.   
Both statements are true.

B.   
First statement is true.
Second statement is false.

C.   
First statement is false. Second statement is true.

D.   
Both statements are false.

1.   
Risk factors associated with Hepatitis C include____________.

A.   
dental and medical procedures

B.   
piercings and tattoos

C.   
blood transfusions and
injected drug use.

D.   
All of the above.

1.   
The most important serologic marker employed
in the diagnosis of hepatitis B infection and its chronic sequelae, is ____________.

A.   
HBsAg

B.   
HBcAg

C.   
HBeAg

D.   
transaminase

1.   
Medical histories are the best way to
determine if a patient is an infectious disease risk. 
The same infection
control procedures should be applied for every patient.

A.   
Both statements are true.

B.   
First statement is true. Second statement is false.

C.   
First statement is false.
Second statement is true.

D.   
Both statements are false.

1.   
A physician reports to you that a patient had
a positive "Australia antigen" determination in 1976.  This test
has to do with the diagnosis of ____________.

A.   
hepatitis D

B.   
hepatitis A

C.   
Both choice A and B.

D.   
Neither choice A nor B.

1.   
The Dane particle is ____________.

A.   
hepatitis A virus

B.   
hepatitis B virion

C.   
hepatitis C particle

D.   
inclusion of hepatitis A virus

E.    
DNA polymerase enzyme

1.   
Hepatitis D appears ____________.

A.   
as a co-infection or
superinfection associated with Hepatitis B

B.   
as a co-infection or superinfection associated with Hepatitis C

C.   
as a co-infection or superinfection associated with Hepatitis A

D.   
as an infection independent of any other Hepatitis virus

1.   
The hepatitis B serologic marker _________ is
most associated with infectivity of hepatitis B infection.

A.   
HBsAg

B.   
HBcAg

C.   
HBeAg

D.   
bilirubin levels in urine

E.    
transaminase

1.   
Hepatitis conditions are generally divided
into ____________ stages.

A.   
prodromal, icteric, and convalescent

B.   
acute, chronic, and necrosis

C.   
inflammation, jaundice, and malaise

D.   
enteral, parenteral, and fulminant

1.   
Clinical signs of jaundice can be detected on
the ____________.

A.   
nail beds

B.   
skin, sclera

C.   
gingiva

D.   
All of the above.

1.   
With HBV, a full recovery occurs by the end of
_________ in 90 – 95% of patients.

A.   
9 weeks

B.   
6 months

C.   
9 months

D.   
12 months

1.   
Hepatitis ______ is the most common chronic
bloodborne infection in the United States.

A.   
hepatitis A

B.   
hepatitis B

C.   
hepatitis C

D.   
hepatitis D